CIK 0001070081 · Large accelerated filer
PTC THERAPEUTICS, INC.
Sign in to watch- Ticker
- PTCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043416587
- Phone
- 9082227000
- Business address
- 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Former names
- PTC THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,752,145
- in 10 filings, $7.8M under 10b5-1 plans
Net −$7,752,145. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-03 | Reeve Emma Director | Option exercise 10b5-1 | +733 | $46.54 | $34K | 7,399 |
| 2025-12-03 | Reeve Emma Director | Sale 10b5-1 | −733 | $78.62 | $58K | 6,666 |
| 2025-12-03 | Reeve Emma Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −733 | 734 | ||
| 2025-12-02 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −3,428 | $79.07 | $271K | 349,964 |
| 2025-12-01 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Grant or award 10b5-1 | +15,625 | 353,392 | ||
| 2025-11-25 | Jacobson Allan Steven Director | Option exercise 10b5-1 | +6,299 | $11.23 | $71K | 23,750 |
| 2025-11-25 | Jacobson Allan Steven Director | Sale 10b5-1 | −2,264 | $82.63 | $187K | 21,486 |
| 2025-11-25 | Jacobson Allan Steven Director | Sale 10b5-1 | −2,510 | $83.93 | $211K | 18,976 |
| 2025-11-25 | Jacobson Allan Steven Director | Sale 10b5-1 | −1,125 | $84.45 | $95K | 17,851 |
| 2025-11-25 | Jacobson Allan Steven Director | Sale 10b5-1 | −400 | $85.24 | $34K | 17,451 |
| 2025-11-25 | Jacobson Allan Steven Director | Option exercise 10b5-1 | +7,900 | $18.01 | $142K | 25,351 |
| 2025-11-25 | Jacobson Allan Steven Director | Sale 10b5-1 | −2,460 | $82.58 | $203K | 22,891 |
| 2025-11-25 | Jacobson Allan Steven Director | Sale 10b5-1 | −3,502 | $83.38 | $292K | 19,389 |
| 2025-11-25 | Jacobson Allan Steven Director | Sale 10b5-1 | −1,238 | $84.47 | $105K | 18,151 |
| 2025-11-25 | Jacobson Allan Steven Director | Sale 10b5-1 | −700 | $85.32 | $60K | 17,451 |
| 2025-11-25 | Jacobson Allan Steven Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,299 | 0 | ||
| 2025-11-25 | Jacobson Allan Steven Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,900 | 0 | ||
| 2025-11-25 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Option exercise 10b5-1 | +2,475 | $18.01 | $45K | 103,100 |
| 2025-11-25 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Sale 10b5-1 | −911 | $82.63 | $75K | 102,189 |
| 2025-11-25 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Sale 10b5-1 | −990 | $83.44 | $83K | 101,199 |
Page 16 of 25 · 493 trades